Legal Representation
Attorney
Donald R, Piper, Jr.
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 7, 2022 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jun 7, 2022 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Nov 24, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 24, 2021 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 24, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 12, 2021 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Oct 5, 2021 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Sep 21, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 21, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 21, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 21, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 21, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 8, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 8, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 8, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 10, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 10, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 10, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 27, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 17, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 6, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Promoting collaboration and the exchange of information and resources within the scientific, research, medical, health care, and business communities to achieve advances in the fields of health care, medicine, and experiential learning and teaching; promoting collaboration and the exchange of information and resources to help test, refine, scale, develop, and deploy health technology products, services and solutions; consulting and advisory services for the health care industry, namely, providing expertise in health care, medicine, and science and promoting and facilitating collaborative and partnership opportunities within the industry and with commercial and financial partners
First Use Anywhere:
Apr 30, 2020
First Use in Commerce:
Apr 30, 2020
Classification
International Classes
035
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"HEALTHTECH LABS"